HLA-DM captures partially empty HLA-DR molecules for catalyzed removal of peptide
about
Human leukocyte Antigen-DM polymorphisms in autoimmune diseasesA step-by-step overview of the dynamic process of epitope selection by major histocompatibility complex class II for presentation to helper T cellsThe Peptide-Receptive Transition State of MHC Class I Molecules: Insight from Structure and Molecular DynamicsHLA-DO acts as a substrate mimic to inhibit HLA-DM by a competitive mechanismCrystal Structure of the HLA-DM–HLA-DR1 Complex Defines Mechanisms for Rapid Peptide SelectionConformational lability in the class II MHC 310 helix and adjacent extended strand dictate HLA-DM susceptibility and peptide exchangeDisruption of Hydrogen Bonds between Major Histocompatibility Complex Class II and the Peptide N-Terminus Is Not Sufficient to Form a Human Leukocyte Antigen-DM Receptive State of Major Histocompatibility Complex Class IISusceptibility to HLA-DM Protein Is Determined by a Dynamic Conformation of Major Histocompatibility Complex Class II Molecule Bound with PeptideAssociation of polymorphisms in HLA antigen presentation-related genes with the outcomes of HCV infectionComprehensive analysis of MHC class II genes in teleost fish genomes reveals dispensability of the peptide-loading DM system in a large part of vertebrates.An unstable Th epitope of P. falciparum fosters central memory T cells and anti-CS antibody responses.The MHC class II cofactor HLA-DM interacts with Ig in B cells.SNP screening of central MHC-identified HLA-DMB as a candidate susceptibility gene for HIV-related Kaposi's sarcomaThe nonconventional MHC class II molecule DM governs diabetes susceptibility in NOD miceThe melting pot of the MHC II peptidomeGenetic variants in antigen presentation-related genes influence susceptibility to hepatitis C virus and viral clearance: a case control study.HLA-DO as the optimizer of epitope selection for MHC class II antigen presentation.Homo-β-amino acid containing MBP(85-99) analogs alleviate experimental autoimmune encephalomyelitis.Self-reactive human CD4 T cell clones form unusual immunological synapsesThe mechanism of HLA-DM induced peptide exchange in the MHC class II antigen presentation pathwayEvaluating the Role of HLA-DM in MHC Class II-Peptide Association Reactions.The Thermodynamic Mechanism of Peptide-MHC Class II Complex Formation Is a Determinant of Susceptibility to HLA-DM.Ubiquitination of HLA-DO by MARCH family E3 ligases.ERAP1-ERAP2 dimers trim MHC I-bound precursor peptides; implications for understanding peptide editing.Thermodynamics of Peptide-MHC Class II Interactions: Not all Complexes are Created Equal.Mechanisms of peptide repertoire selection by HLA-DMSmall molecule inhibitor of antigen binding and presentation by HLA-DR2b as a therapeutic strategy for the treatment of multiple sclerosis.Conformational variation in structures of classical and non-classical MHCII proteins and functional implications.HLA-DM: arbiter conformationis.Re-Directing CD4(+) T Cell Responses with the Flanking Residues of MHC Class II-Bound Peptides: The Core is Not Enough.Structural Characteristics of HLA-DQ that May Impact DM Editing and Susceptibility to Type-1 Diabetes.HLA-DM Focuses on Conformational Flexibility Around P1 Pocket to Catalyze Peptide Exchange.MHC class II antigen presentation by dendritic cells regulated through endosomal sorting.HLA-DM and HLA-DO, key regulators of MHC-II processing and presentation.Measurement of Peptide Binding to MHC Class II Molecules by Fluorescence Polarization.Structural Insights Into HLA-DM Mediated MHC II Peptide Exchange.Determinants of immunodominance for CD4 T cells.Disruption of HLA class II antigen presentation in Burkitt lymphoma: implication of a 47,000 MW acid labile protein in CD4+ T-cell recognition.Peptidomic analysis of type 1 diabetes associated HLA-DQ molecules and the impact of HLA-DM on peptide repertoire editing.Major Histocompatibility Complex (MHC) Class I and MHC Class II Proteins: Conformational Plasticity in Antigen Presentation.
P2860
Q26741035-CBB16BCD-6FBD-4CAE-8097-C81A96E9E81AQ26747063-775ED04D-C760-4F8B-925B-3B87E976D7B9Q27670624-D947C566-7397-4581-8DE7-98B5AA44C6BDQ27675409-43A73AFC-D5D9-4252-9F26-C8C8FA699534Q27675568-25DAF970-F1EB-4B96-9215-57C2287109E1Q27675571-3B0A8339-503F-4BE6-96ED-93EA98F8FAA4Q27679799-0ECF39D7-C995-462A-82D0-9D2837C094CBQ27684590-D270E819-C00F-401B-90C8-C2C8950EB05CQ28546144-4DD84EA2-2A44-40A7-A9F6-DA72E6774B7AQ31144496-198CAC7A-BF25-4007-8C8E-8DBB3805E56EQ33830488-8B14D6FF-2AD2-4B0F-A531-91B869C3E1FBQ34146546-4EC9516A-6E5B-4523-B511-07E439D44EDFQ34240359-E524FA48-D563-4BB0-BA3F-B10454765D46Q34590244-161C5609-C46B-4AD8-80B4-BC3E751902BAQ34676583-40A2EEF0-7F11-4396-893B-C8C6A8681D43Q34787490-652DF2F5-440A-4D1D-93FF-D2098E8724E7Q34948997-29EFA62F-237C-4D88-8EC0-DD6C80008C2EQ35040831-1E78A648-67F7-4B0E-B89C-D27231118B28Q35760826-C6AD535C-A947-489A-AD42-BCE4A14E8F3BQ35785432-86210FAF-52C5-4FEC-94B7-684A1E26504AQ35815584-9C97248D-BC84-4880-997F-B5FCE502CEEDQ35861946-2E5CF080-2D2C-4D3D-848F-CCE40ACA5418Q36848435-55136790-2305-44D0-B19F-DDCDFC41DAC9Q37168911-08A9A473-BC43-4C4F-A8EC-EA5E3177A053Q37208000-6A7CC51F-8EF9-43AF-A047-E16BD160AF8EQ37228066-F63E3A86-7C3B-4379-8C65-046DE8A99EF5Q37478921-A3E596ED-1ECD-4AD5-A263-89783EC3FDC0Q38050482-050BFA2E-44D2-42D2-A0AC-A01B56526916Q38056763-84CCE375-D1D1-4AD6-9AA3-D24C0A908CF2Q38121075-5613230B-D8ED-484A-A05A-E645E5F6EBD2Q38134730-9B925A5F-AAFC-4E86-991C-AB9E7C69C97EQ38154571-0631DC4B-25FA-4074-9181-2CC2854F4DE2Q38167996-497E342D-C3FA-4FD0-B567-99EAC05C4915Q38181859-BB74E397-1B9A-4DFF-B4DD-E49F4EADADA0Q38235847-C5C66DBF-9998-43D4-AD50-08FC5AF95061Q38255165-1A8721CA-C5D8-4888-A312-360E8540F533Q38313559-203F252D-CC73-4CA7-93A4-710DB0030E2CQ39015659-3E073161-41F1-4BAB-92B2-9E9F3B6D30D1Q39175672-990BF354-ACDD-4274-B3D6-436A3D2A6B72Q39214326-BC00112A-F6F3-4889-9DC7-DF0D8852B8D3
P2860
HLA-DM captures partially empty HLA-DR molecules for catalyzed removal of peptide
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
HLA-DM captures partially empty HLA-DR molecules for catalyzed removal of peptide
@ast
HLA-DM captures partially empty HLA-DR molecules for catalyzed removal of peptide
@en
type
label
HLA-DM captures partially empty HLA-DR molecules for catalyzed removal of peptide
@ast
HLA-DM captures partially empty HLA-DR molecules for catalyzed removal of peptide
@en
prefLabel
HLA-DM captures partially empty HLA-DR molecules for catalyzed removal of peptide
@ast
HLA-DM captures partially empty HLA-DR molecules for catalyzed removal of peptide
@en
P2093
P2860
P356
P1433
P1476
HLA-DM captures partially empty HLA-DR molecules for catalyzed removal of peptide
@en
P2093
Anne-Kathrin Anders
David A Schubert
Kai W Wucherpfennig
Kevin D Fowler
Melissa J Call
Monika-Sarah E D Schulze
Nilufer P Seth
P2860
P356
10.1038/NI.1967
P407
P577
2010-12-05T00:00:00Z